Founder · Immuneel Therapeutics

Siddhartha Mukherjee

Co-founder & Oncologist of Immuneel Therapeutics, a biotechnology company based in Bengaluru.

Co-founder · OncologistBengaluruBiotechnology
Founded
2019
Bengaluru, Karnataka, India
Raised to date
₹100 crore
1 round on record
Latest round
Series B
₹100 crore · Jun 2026

About

Siddhartha Mukherjee is Co-founder & Oncologist of Immuneel Therapeutics, a biotechnology company based in Bengaluru, founded in 2019. Immuneel Therapeutics's most recent disclosed round was a Series B of ₹100 crore in Jun 2026.

Compiled from StartupFox records · updates as coverage is published

Company

Est. 2019
Immuneel Therapeutics
Biotechnology · Bengaluru

Immuneel Therapeutics is an Indian cell and gene therapy company developing CAR-T treatments for blood cancers. Its lead product, Qartemi, is an indigenously developed CD19-targeted CAR-T therapy approved in India for relapsed or refractory B-cell lymphoma.

Funding
Jun 2026Series B₹100 croreSingularity AMC, Rainmatter, Eight Roads Ventures, F-Prime Capital
Company profile →1 round on record

Journey with Immuneel Therapeutics

1 milestone
  1. Jun 2026Milestone

    Scaling Qartemi — India's first indigenously developed and approved CAR-T therapy — with GMP expansion and entry into APAC and the Middle East. Read the story →

Also building Immuneel Therapeutics

KMKiran Mazumdar-ShawCo-founder · Founder, Biocon→

Coverage

1 story
Funding · 8 Jun 2026 · 2 min read
Immuneel Therapeutics Raises Over ₹100 Crore in Series B Round to Scale Indigenous CAR-T Cancer Therapy